treatment
DATA SYNTHESIS: Montelukast is approved for the       prophylaxis and chronic treatment of asthma at a dose of 10 mg once daily for       adolescents (> or =15 y) and adults and 5 mg once daily for children (6-14 y).
DATA SYNTHESIS:  @OBJECT$  is approved  @PREDICAT$  the       prophylaxis and chronic  @SUBJECT$  of asthma at a dose of 10 mg once daily for       adolescents (> or =15 y) and adults and 5 mg once daily for children (6-14 y).